Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$693 Buy
+8
New +$683 ﹤0.01% 2828
2026
Q1
Sell
-51
Closed -$4.74K 2554
2025
Q4
$4.74K Buy
51
+19
+59% +$2.07K ﹤0.01% 2029
2025
Q3
$3.99K Sell
32
-85
-73% -$10.8K ﹤0.01% 2242
2025
Q2
$15.4K Buy
117
+41
+54% +$4.64K ﹤0.01% 1732
2025
Q1
$7.96K Hold
76
﹤0.01% 1669
2024
Q4
$8.25K Buy
76
+25
+49% +$2.79K ﹤0.01% 1626
2024
Q3
$5.45K Hold
51
﹤0.01% 1699
2024
Q2
$5.05K Buy
+51
New +$5.13K ﹤0.01% 1687

Other funds holding ITRI

Clearstead Advisors's ITRI Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Itron (ITRI) in Q2 2026: 8 shares worth $693. The stake represents ﹤0.01% of the portfolio and ranks #2828 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ITRI as recently as Q4 2025.

Clearstead Advisors first reported a position in ITRI in Q2 2024 and has held it in 8 quarters since. The position peaked at $15.4K in Q2 2025. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Clearstead Advisors held 8 shares of Itron worth $693 as of Q2 2026.
  • Itron was a new Clearstead Advisors position in Q2 2026.
  • Itron made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2828 holding.
  • Clearstead Advisors first reported a position in Itron in Q2 2024 and has held it in 8 quarters since.
  • Clearstead Advisors's Itron position peaked at $15.4K in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.